Angiotensin II and VEGF are involved in angiogenesis induced by short-term exercise training

被引:125
作者
Amaral, SL
Papanek, PE
Greene, AS
机构
[1] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA
[2] Marquette Univ, Milwaukee, WI 53201 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2001年 / 281卷 / 03期
关键词
growth factors; skeletal muscle; angiotensin-converting inhibitors; losartan;
D O I
10.1152/ajpheart.2001.281.3.H1163
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Results from our laboratory have suggested a pathway involving angiotensin II type I (AT(1)) receptors and vascular endothelial growth factor (VEGF) in angiogenesis induced by electrical stimulation. The present study investigated if similar mechanisms underlie the angiogenesis induced by short-term exercise training. Seven days before training and throughout the training period, male Sprague-Dawley rats received either captopril or losartan in their drinking water. Rats underwent a 3-day treadmill training protocol. The tibialis anterior and gastrocnemius muscles were harvested under anesthesia and lightly fixed in formalin (vessel density) or frozen in liquid nitrogen (VEGF expression). In controls, treadmill training resulted in a significant increase in vessel density in all muscles studied. However, the angiogenesis induced by exercise was completely blocked by either losartan or captopril. Western blot analysis showed that VEGF expression was increased in the exercised control group, and both losartan and captopril blocked this increase. The role of VEGF was directly confirmed using a VEGF-neutralizing antibody. These results confirm the role of angiotensin II and VEGF in angiogenesis induced by exercise.
引用
收藏
页码:H1163 / H1169
页数:7
相关论文
共 37 条
[31]   Angiogenic growth factor mRNA responses to passive and contraction-induced hyperperfusion in skeletal muscle [J].
Roca, J ;
Gavin, TP ;
Jordan, M ;
Siafakas, N ;
Wagner, H ;
Benoit, H ;
Breen, E ;
Wagner, PD .
JOURNAL OF APPLIED PHYSIOLOGY, 1998, 85 (03) :1142-1149
[32]   Upregulation of angiotensin-converting enzyme by vascular endothelial growth factor [J].
Saijonmaa, O ;
Nyman, T ;
Kosonen, R ;
Fyhrquist, F .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 280 (02) :H885-H891
[33]   VASCULAR ENDOTHELIAL GROWTH-FACTOR INDUCED BY HYPOXIA MAY MEDIATE HYPOXIA-INITIATED ANGIOGENESIS [J].
SHWEIKI, D ;
ITIN, A ;
SOFFER, D ;
KESHET, E .
NATURE, 1992, 359 (6398) :843-845
[34]   Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats [J].
Volpert, OV ;
Ward, WF ;
Lingen, MW ;
Chesler, L ;
Solt, DB ;
Johnson, MD ;
Molteni, A ;
Polverini, PJ ;
Bouck, NP .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (03) :671-679
[35]   ANGIOTENSIN-II INCREASES VASCULAR-PERMEABILITY FACTOR GENE-EXPRESSION BY HUMAN VASCULAR SMOOTH-MUSCLE CELLS [J].
WILLIAMS, B ;
BAKER, AQ ;
GALLACHER, B ;
LODWICK, D .
HYPERTENSION, 1995, 25 (05) :913-917
[36]   Mechanisms of coronary angiogenesis in response to stretch:: role of VEGF and TGF-β [J].
Zheng, W ;
Seftor, EA ;
Meininger, CJ ;
Hendrix, MJC ;
Tomanek, RJ .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 280 (02) :H909-H917
[37]   Bradycardia-induced coronary angiogenesis is dependent on vascular endothelial growth factor [J].
Zheng, W ;
Brown, MD ;
Brock, TA ;
Bjercke, RJ ;
Tomanek, RJ .
CIRCULATION RESEARCH, 1999, 85 (02) :192-198